Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention.

[1]  J. Huttunen,et al.  Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. , 1990, Arteriosclerosis.

[2]  J. Breslow,et al.  Genetic basis of lipoprotein disorders. , 1995, The Journal of clinical investigation.

[3]  T. Miettinen,et al.  Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. , 1989, The American journal of clinical nutrition.

[4]  M. Nieminen,et al.  Apoprotein E Polymorphism and Coronary Artery Disease: Increased Prevalence of Apolipoprotein E‐4 in Angiographically Verified Coronary Patients , 1989, Arteriosclerosis.

[5]  H. Gylling,et al.  SERUM CHOLESTEROL RESPONSE TO DIETARY CHOLESTEROL AND APOPROTEIN E PHENOTYPE , 1988, The Lancet.

[6]  J. Huttunen,et al.  Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. , 1988, JAMA.

[7]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[8]  J. Metso,et al.  Apolipoprotein A-IV polymorphism in the Finnish population: gene frequencies and description of a rare allele. , 1988, Human heredity.

[9]  J. Huttunen,et al.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.

[10]  O. Heinonen,et al.  Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial. , 1987, European heart journal.

[11]  J. Huttunen,et al.  The Helsinki Heart Study: basic design and randomization procedure. , 1987, European heart journal.

[12]  C. Ehnholm,et al.  Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. , 1987, The Journal of clinical investigation.

[13]  C. Sing,et al.  Apolipoprotein E polymorphism and plasma cholesterol response to probucol. , 1987, Metabolism: clinical and experimental.

[14]  P. de Knijff,et al.  A rapid micromethod for apolipoprotein E phenotyping directly in serum. , 1987, Journal of lipid research.

[15]  G. Assmann,et al.  Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. , 1986, Clinical chemistry.

[16]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[17]  C. Ehnholm,et al.  Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. , 1986, Journal of lipid research.

[18]  F. W. Robertson,et al.  Effects of Apoprotein E Polymorphism on Serum Lipoprotein Concentration , 1985, Arteriosclerosis.

[19]  C. Sing,et al.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. , 1985, American journal of human genetics.

[20]  W. A. Bradley,et al.  Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. , 1984, The Journal of biological chemistry.

[21]  G. Assmann,et al.  Apolipoprotein E polymorphism and hyperlipidemia. , 1984, Clinical chemistry.

[22]  F. W. Robertson,et al.  Polymorphism at the Apoprotein‐E locus in relation to risk of coronary disease , 1984, Clinical genetics.

[23]  G. Assmann,et al.  Apolipoprotein E Polymorphism and Coronary Artery Disease , 1983, Arteriosclerosis.

[24]  R. Mahley,et al.  Lipoprotein receptors and cholesterol homeostasis. , 1983, Biochimica et biophysica acta.

[25]  J. Breslow,et al.  Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. , 1981, Biochemistry.

[26]  G. Utermann,et al.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man , 1977, Nature.

[27]  A. W. Pinrton.  The Invisible Worm , 1976, The Lancet.

[28]  G. Kostner.  Letter: Enzymatic determination of cholesterol in high-density lipoprotein fractions prepared by polyanion precipitation. , 1976, Clinical chemistry.

[29]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.